lilly direct tirzepatide Eli Lilly, Maker of Mounjaro and Zepbound, Wades Into Telehealth Lilly CEO says weight-loss drug

Patent infringement lawsuits typically take 3-5 years to be completed and the vast majority (95-97%) result in a private settlement where the details are not disclosed due to confidentiality clauses

It is especially appealing to people who want help making the routine feel more manageable

In December 2025, Eli Lilly announced $3 billion expansion of its Wisconsin facility to meet surging demand for GLP-1 drugs like Zepbound and Mounjaro

We will also continue to advocate for a system that better aligns with the science." In a clinical study, tirzepatide 5 mg, along with a reduced calorie diet and increased physical activity, achieved an average of 15% weight loss over 72 weeks compared to 3.1% for placebo